3671 Stock Overview
Softmax Co., Ltd develops, sales, introduction, and maintenance of corporate systems.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Softmax Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥800.00 |
52 Week High | JP¥830.00 |
52 Week Low | JP¥688.00 |
Beta | 0.95 |
1 Month Change | -2.32% |
3 Month Change | 6.52% |
1 Year Change | 9.89% |
3 Year Change | -27.34% |
5 Year Change | 6.15% |
Change since IPO | -19.73% |
Recent News & Updates
Recent updates
Shareholder Returns
3671 | JP Healthcare Services | JP Market | |
---|---|---|---|
7D | -0.1% | 1.7% | 1.8% |
1Y | 9.9% | -34.9% | 31.0% |
Return vs Industry: 3671 exceeded the JP Healthcare Services industry which returned -34.9% over the past year.
Return vs Market: 3671 underperformed the JP Market which returned 31% over the past year.
Price Volatility
3671 volatility | |
---|---|
3671 Average Weekly Movement | 2.5% |
Healthcare Services Industry Average Movement | 6.5% |
Market Average Movement | 4.1% |
10% most volatile stocks in JP Market | 8.1% |
10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 3671 has not had significant price volatility in the past 3 months.
Volatility Over Time: 3671's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1974 | 211 | Toshiro Horie | www.s-max.co.jp |
Softmax Co., Ltd develops, sales, introduction, and maintenance of corporate systems. It is also involved in medical information system development. The company also offers web based electronic medical record system, web based ordering system, medical accounting, radiology information, rehabilitation department system, health check-up system, nursing work management system, and surgical department system.
Softmax Co., Ltd Fundamentals Summary
3671 fundamental statistics | |
---|---|
Market cap | JP¥4.80b |
Earnings (TTM) | JP¥452.00m |
Revenue (TTM) | JP¥5.26b |
10.6x
P/E Ratio0.9x
P/S RatioIs 3671 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3671 income statement (TTM) | |
---|---|
Revenue | JP¥5.26b |
Cost of Revenue | JP¥3.70b |
Gross Profit | JP¥1.57b |
Other Expenses | JP¥1.11b |
Earnings | JP¥452.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 13, 2024
Earnings per share (EPS) | 75.35 |
Gross Margin | 29.75% |
Net Profit Margin | 8.59% |
Debt/Equity Ratio | 41.3% |
How did 3671 perform over the long term?
See historical performance and comparison